KANEKA CORPORATION
Main Filters
KANEKA CORPORATION
KANEKA CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
347-404U | 0 | - | ||
371-041010 | 0 | - | ||
371-041015 | 0 | - | ||
372-041020 | 0 | - | ||
372-041030 | 0 | - | ||
373-040810 | 0 | - | ||
373-040815 | 0 | - | ||
373-040830 | 0 | - | ||
373-051230 | 0 | - | ||
373-051250 | 0 | - | ||
373-122050 | 0 | - | ||
374-142450 | 0 | - | ||
390-0101 | 0 | - | ||
390-0102 | 0 | - | ||
390-0103 | 0 | - | ||
390-01H2 | 0 | - | ||
390-01H3 | 0 | - | ||
390-0203 | 0 | - | ||
390-0204 | 0 | - | ||
390-0206 | 0 | - | ||
390-0208 | 0 | - | ||
390-02H4 | 0 | - | ||
390-02H6 | 0 | - | ||
390-0304 | 0 | - | ||
390-0306 | 0 | - | ||
390-0308 | 0 | - | ||
392-0304 | 0 | - | ||
392-0306 | 0 | - | ||
392-03H8 | 0 | - | ||
392-0410 | 0 | - | ||
392-0510 | 0 | - | ||
392-0515 | 0 | - | ||
392-0620 | 0 | - | ||
392-0730 | 0 | - | ||
392-0840 | 0 | - | ||
392-0940 | 0 | - | ||
392-1040 | 0 | - | ||
392-1250 | 0 | - | ||
392-1450 | 0 | - | ||
392-1650 | 0 | - | ||
393-020304 | 0 | - | ||
393-020306 | 0 | - | ||
393-020310 | 0 | - | ||
393-030515 | 0 | - | ||
393-030520 | 0 | - | ||
BD-Q60200ER | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - |
1,047 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Lixelle
KANEKA CORPORATION
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
0
-
Lixelle
KANEKA CORPORATION
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
0
-
Lixelle
KANEKA CORPORATION
The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
0
-
LIPOSORBER
KANEKA CORPORATION
Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
0
-
EDG v4
KANEKA CORPORATION
ELECTRO DETACH GENERATOR v4 (Model: “EDG v4”) is used to detach the platinum coil from the pusher of i-ED COIL manufactured by Kaneka Corporation.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
i-ED COIL
KANEKA CORPORATION
The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel.
0
-
R2P CROSSTELLA RX
KANEKA CORPORATION
R2P CROSSTELLA RX is a Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter for peripheral indications. R2P CROSSTELLA RX is a rapid exchange (RX) type and the maximum diameter of the compatible guidewire is 0.018 inches (0.46mm).